Key Insights

Highlights

Success Rate

89% trial completion (above average)

Research Maturity

59 completed trials (44% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.2%

7 terminated out of 134 trials

Success Rate

89.4%

+2.9% vs benchmark

Late-Stage Pipeline

12%

16 trials in Phase 3/4

Results Transparency

15%

9 of 59 completed with results

Key Signals

9 with results89% success

Data Visualizations

Phase Distribution

84Total
Not Applicable (31)
P 1 (19)
P 2 (18)
P 3 (6)
P 4 (10)

Trial Status

Completed59
Unknown35
Recruiting16
Terminated7
Not Yet Recruiting6
Withdrawn5

Trial Success Rate

89.4%

Benchmark: 86.5%

Based on 59 completed trials

Clinical Trials (134)

Showing 20 of 20 trials
NCT01366144Phase 1Active Not Recruiting

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

NCT07727759Not Yet Recruiting

CT Volumetry and Hepatic Vascular Deformation Mapping to Predict Post-Hepatectomy Liver Failure

NCT05045794Not ApplicableCompleted

Bridge to HOPE: Hypothermic Oxygenated Perfusion Versus Cold Storage Prior to Liver Transplantation

NCT05234190Phase 1Active Not Recruiting

Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients

NCT02991105Active Not Recruiting

Epidemiology of Complications After Solid Organ Transplantation - EpCOT Study

NCT07634562Phase 1Not Yet RecruitingPrimary

TLI- and ATG-Enabled Minimization Protocol in Liver Transplantation

NCT04617522Phase 1Recruiting

Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment

NCT03265249Not ApplicableTerminatedPrimary

BRIDGE Device for Post-operative Pain Control

NCT07578441Enrolling By Invitation

VitaSmart HOPE System: Bridge to HOPE Registry

NCT07595627Not ApplicableNot Yet Recruiting

Hypothermic Machine Perfusion for Liver Graft Preservation

NCT07548190Active Not RecruitingPrimary

Bidirectional Cohort Study of a Prognosis Model for Acute-on-chronic Liver Failure

NCT07312864Phase 1RecruitingPrimary

Safety and Tolerability Study of a Novel Bioartificial Liver in Liver Failure and Small-for-Size Syndrome

NCT06904755Phase 1RecruitingPrimary

Safety and Effectiveness of Mesenchymal Stem Cells in Blood Purification for the Treatment of Liver Failure

NCT06366048RecruitingPrimary

A Study on Relationship Between Resected Normal Liver Parenchymal Volume(RNLV)and Post-Hepatectomy Liver Failure (PHLF)

NCT05726032Phase 2Recruiting

Empagliflozin in Patients With Cirrhosis and Ascites

NCT07362745Completed

Single-Cell and Spatial Transcriptomics Analysis of Steatotic Donor Liver Susceptibility to Post-Transplant Injury

NCT04618692Not ApplicableCompletedPrimary

Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation

NCT05517668Phase 2Terminated

Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose

NCT04447911Phase 4Recruiting

Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia

NCT06871111Phase 1Recruiting

The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial

Scroll to load more

Research Network

Activity Timeline